United Kingdom

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

22 Nov 2017
Change (% chg)

$1.94 (+2.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

AmerisourceBergen to acquire H. D. Smith
Monday, 20 Nov 2017 

Nov 20 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen to acquire H. D. Smith.AmerisourceBergen Corp - deal for ‍$815 million in cash​.AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​.AmerisourceBergen Corp - ‍acquisition is expected to be slightly accretive to adjusted diluted EPS in fiscal year 2018​.AmerisourceBergen Corp - ‍acquisition expected to achieve full run-rate synergies, be about $0.15 accretive to adjusted EPS in FY 2020​.AmerisourceBergen Corp - ‍company now expects fiscal year 2018 adjusted operating income growth to be in range of 4 percent to 7 percent​.AmerisourceBergen Corp - now sees revenue growth to be in range of 8 percent to 11 percent​ for fiscal year 2018.AmerisourceBergen Corp - ‍reaffirming rest of previously announced fiscal 2018 financial guidance​.AmerisourceBergen - expects fiscal year 2018 pharmaceutical distribution services segment operating income growth in range of 4 percent to 7 percent​.  Full Article

AmerisourceBergen increases dividend 4 percent
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Amerisourcebergen Corp ::Increases dividend 4 percent.Increased company's quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share​​.  Full Article

AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention​.AmerisourceBergen CFO, on conf call - continue to experience headwind from lower Hepatitis C revenues this quarter, consistent with overall U.S. market trends.AmerisourceBergen CFO, on conf call - continue to see strong volume, revenue growth for oncology drugs due to expanded indications of overall market growth.AmerisourceBergen CFO, on conf call says our PharMEDium business experienced an increase in sequential shipping volumes in Q4.AmerisourceBergen CFO, on conf call, says current trends indicate that the generic buy side deflation rate has not worsened.AmerisourceBergen CFO, on conf call, says it is likely that only Q4 will have a full benefit of new pharmacies from Walgreens-Rite Aid deal.AmerisourceBergen CFO, on conf call, says transitioning customer contracts to more "balanced pricing" to offset lower contributions from generics.AmerisourceBergen, on conf call, when asked about Amazon's entry into drug supply chain, says "we haven't really counted Amazon at all yet as a threat".  Full Article

AmerisourceBergen Q3 GAAP earnings per share $1.56
Tuesday, 2 Aug 2016 

AmerisourceBergen Corp : AmerisourceBergen reports third quarter fiscal year 2016 results . Q3 revenue $36.9 billion versus I/B/E/S view $36.71 billion . Q3 GAAP earnings per share $1.56 . Q3 adjusted earnings per share $1.37 excluding items . Sees FY 2016 adjusted earnings per share $5.52 to $5.57 . Q3 earnings per share view $1.27 -- Thomson Reuters I/B/E/S . Sees FY 2016 capital expenditures in $400 million range . Sees FY revenue growth of approximately 8 percent . Amerisourcebergen says fy 2017 adjusted earnings per share is expected to grow in range of 4 to 6 percent above midpoint of updated fiscal 2016 guidance . FY 2017 earnings per share view $5.82 -- Thomson Reuters I/B/E/S . AmerisourceBergen says continue to expect gross profit in Q4 to be negatively impacted by headwinds co identified in early May . AmerisourceBergen says continues to expect that headwinds that are impacting fiscal 2016 will continue well into fiscal 2017 .Now expects share repurchases under co's regular programs of about $350 million, as well as special share repurchases to satisfy hedging programs.  Full Article

AmerisourceBergen Corp and publix announce distribution agreement
Thursday, 4 Feb 2016 

AmerisourceBergen Corp:AmerisourceBergen and publix announce distribution agreement.Long-term agreement encompassing the distribution of branded, generic and over-the-counter health and pharmaceutical products.  Full Article

UPDATE 1-AmerisourceBergen to pay $625 mln to settle U.S. government probe

Nov 21 A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.